Financials in USD. Standardized financial statements.
A compact view of how Together Pharma Ltd turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $91.01M | $31.23M | $12.03M | $11.22M | $0 | $0 | $0 | $0 | $12.11M | $7.59M |
| Revenue Growth? | +191.4% | +159.7% | +7.2% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | +59.7% | 0.0% |
| Cost of Revenue? | $56.38M | $37.12M | $14.20M | $17.06M | $1.42M | $86,000 | $10,790 | $15,355 | $4.90M | $4.69M |
| Gross Profit? | $34.62M | -$5.89M | -$2.17M | -$5.84M | -$1.42M | -$86,000 | -$10,790 | -$15,355 | $7.21M | $2.90M |
| Gross Margin? | +38.0% | -18.9% | -18.1% | -52.0% | 0.0% | 0.0% | 0.0% | 0.0% | +59.6% | +38.2% |
| Operating Expenses? | $12.53M | $13.42M | $9.03M | $11.16M | $14.48M | $145.78M | $51,000 | $2.00M | $3.35M | $8.60M |
| Operating Income? | $22.09M | -$19.77M | -$11.46M | $16.63M | -$15.38M | -$3.70M | -$51,000 | -$3.24M | -$3.25M | -$6.61M |
| EBITDA? | $27.62M | -$14.37M | -$6.14M | $20.55M | -$13.96M | -$3.62M | $17,000 | -$3.04M | -$2.78M | -$6.21M |
| Income Before Tax | $1.54M | -$36.33M | -$15.12M | $14.16M | -$16.66M | -$149.89M | -$51,000 | -$1.73M | -$3.84M | -$5.53M |
| Income Tax Expense | $4.07M | -$847,000 | $0 | -$1.31M | $0 | -$26,000 | $0 | $0 | $0 | -$62,340 |
| Net Income? | -$4.32M | -$33.52M | -$13.78M | $7.15M | -$15.28M | -$149.86M | -$34,000 | -$1.73M | -$3.84M | -$5.47M |
| EPS? | $-0.49 | $-4.18 | $-2.23 | $1.22 | $-3.51 | $-36.20 | $-0.01 | $-2.93 | $-8.41 | $-15.63 |
| Diluted EPS? | $-0.49 | $-4.11 | $-2.01 | $1.24 | $-3.04 | $-35.94 | $-0.01 | $-2.93 | $-8.41 | $-15.63 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality